Literature DB >> 29268345

Surgery for limited-stage small cell lung cancer: ready for prime-time?

Vinicius Ernani1, Apar Kishor Ganti1,2.   

Abstract

Entities:  

Year:  2017        PMID: 29268345      PMCID: PMC5723782          DOI: 10.21037/jtd.2017.09.43

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Authors:  J P Pignon; R Arriagada; D C Ihde; D H Johnson; M C Perry; R L Souhami; O Brodin; R A Joss; M S Kies; B Lebeau
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

Review 2.  Surgery for early-stage small cell lung cancer.

Authors:  Bryan J Schneider; Ashish Saxena; Robert J Downey
Journal:  J Natl Compr Canc Netw       Date:  2011-10       Impact factor: 11.908

3.  Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus.

Authors:  A B Miller; W Fox; R Tall
Journal:  Lancet       Date:  1969-09-06       Impact factor: 79.321

4.  Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.

Authors:  Malcolm V Brock; Craig M Hooker; James E Syphard; William Westra; Li Xu; Anthony J Alberg; David Mason; Stephen B Baylin; James G Herman; Rex C Yung; Julie Brahmer; Charles M Rudin; David S Ettinger; Stephen C Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2005-01       Impact factor: 5.209

5.  Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

Authors:  Ramaswamy Govindan; Nathan Page; Daniel Morgensztern; William Read; Ryan Tierney; Anna Vlahiotis; Edward L Spitznagel; Jay Piccirillo
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

6.  Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?

Authors:  David Schreiber; Justin Rineer; Jeremy Weedon; Dan Vongtama; Angela Wortham; Anne Kim; Peter Han; Kwang Choi; Marvin Rotman
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

7.  The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Eric Vallières; Frances A Shepherd; John Crowley; Paul Van Houtte; Pieter E Postmus; Desmond Carney; Kari Chansky; Zeba Shaikh; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-09       Impact factor: 15.609

8.  The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate.

Authors:  Eric Lim; Elizabeth Belcher; Yoon Khoong Yap; Andrew G Nicholson; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2008-11       Impact factor: 15.609

9.  A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy.

Authors:  T Lad; S Piantadosi; P Thomas; D Payne; J Ruckdeschel; G Giaccone
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

10.  Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.

Authors:  James B Yu; Roy H Decker; Frank C Detterbeck; Lynn D Wilson
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

View more
  2 in total

1.  Surgery for small cell lung cancer in the modern era: opportunities and challenges.

Authors:  Elliot Wakeam
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A-M C Dingemans; M Früh; A Ardizzoni; B Besse; C Faivre-Finn; L E Hendriks; S Lantuejoul; S Peters; N Reguart; C M Rudin; D De Ruysscher; P E Van Schil; J Vansteenkiste; M Reck
Journal:  Ann Oncol       Date:  2021-04-20       Impact factor: 51.769

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.